Literature DB >> 21851553

Medical devices in dermatology: topical semi-solid formulations for the treatment of skin diseases.

Hans Christian Korting1, Claudia Schöllmann.   

Abstract

In recent years, topically applied semi-solid formulations certified as medicals devices and not as topical drugs are increasingly used for the treatment of skin diseases. Medical devices primarily unfold their therapeutic effect by physical means, not by pharmacological, immunological or metabolic means. Intensified placing of medical devices on the dermatological market may at least partly be explained by a less complex marketing authorization process compared to topical drugs. If the requirements are fulfilled to certify a product as a medical device the opportunity will be offered to quickly introduce innovations onto the market and propagate them. A variety of evidence-based medical devices for several dermatological indications are presented here.
© The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21851553     DOI: 10.1111/j.1610-0387.2011.07764.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  4 in total

1.  Prescribing Pattern of Dermatological Compounding in Ethiopia: The Case of ALERT Hospital.

Authors:  Muluken Nigatu Selam; Andualem Ababu; Regasa Bayisa; Mahdi Abdella; Edessa Diriba; Minychel Wale; Tadesse Alemu; Tesfa Marew; Assefa Mulu Baye
Journal:  Integr Pharm Res Pract       Date:  2022-01-06

Review 2.  Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications.

Authors:  Paloma Juarez; Vikram Virdi; Ann Depicker; Diego Orzaez
Journal:  Plant Biotechnol J       Date:  2016-02-13       Impact factor: 9.803

Review 3.  Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis.

Authors:  Jaime Piquero-Casals; Doris Hexsel; Juan Francisco Mir-Bonafé; Eduardo Rozas-Muñoz
Journal:  Dermatol Ther (Heidelb)       Date:  2019-08-08

4.  Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study.

Authors:  Virginia Garofalo; Maria Vittoria Cannizzaro; Sara Mazzilli; Luca Bianchi; Elena Campione
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.